Aetna's CEO envisions CVS deal helping it lead the way on social determinants of health (SDOH); the Senate health chair releases 2 draft bills on opioids; the medical community criticizes former Senator Rick Santorum, R-Pennsylvania, for suggesting student activitists learn CPR instead of advocating for gun control.
In an interview with The Washington Post, Aetna’s chief executive said its merger with CVS could allow it to act as a neighborhood gateway focusing more on the social determinants of health (SDOH). Mark T. Bertolini said the $69 billion deal could lead to a future where pharmacists or medical professionals could assist with appointments or focus on nonmedical support, such as coordinating rides, meal assistance, nutrition counseling, or social supports.
Senate Health Committee Chairman Lamar Alexander, R-Tennessee, released 2 draft bills aimed at curbing the overprescribing of opioids and stopping fentanyl, a synthetic opioid, at the border, The Hill reported. One bill would let the FDA require drug manufacturers to package certain opioids in blister packs, making it easier for a doctor to write a smaller quantity. The other bill would ensure the FDA can spend the $94 million included in the omnibus bill passed last week to boost laboratory capabilities and upgrade other methods to combat fentanyl.
Healthcare professionals, especially surgeons who have operated on gunshot victims, criticized former Senator Rick Santorum, R-Pennsylvania, after he suggested that student activists should learn CPR instead of protesting for gun control. Doctors took to Twitter to share their opinions and also in magazines sharing their experiences operating on children and young adults, like a Tenessee surgeon, Eugene Gu, MD, who penned an article in Tuesday's Newsweek.
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More